A Deep Learning–Based Assay for Programmed Death Ligand 1 Immunohistochemistry Scoring in Non–Small Cell Lung Carcinoma: Does it Help Pathologists Score?
Modern Pathology · 2024
DOI: 10.1016/j.modpat.2024.100485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2024. Verfasst von Hiroaki Ito und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Deep Learning, B7-H1 Antigen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Several studies have developed various artificial intelligence (AI) models for immunohistochemical analysis of programmed death ligand 1 (PD-L1) in patients with non-small cell lung carcinoma; however, none have focused on specific ways by which AI-assisted systems could help pathologists determine the tumor proportion score (TPS). In this study, we developed an AI model to calculate the TPS of the PD-L1 22C3 assay and evaluated whether and how this AI-assisted system could help pathologists determine the TPS and analyze how AI-assisted systems could affect pathologists' assessment accuracy. We assessed the 4 methods of the AI-assisted system: (1 and 2) pathologists first assessed and then referred to automated AI scoring results (1, positive tumor cell percentage; 2, positive tumor cell percentage and visualized overlay image) for final confirmation, and (3 and 4) pathologists referred to the automated AI scoring results (3, positive tumor cell percentage; 4, positive tumor cell percentage and visualized overlay image) while determining TPS. Mixed-model analysis was used to calculate the odds ratios (ORs) with 95% CI for AI-assisted TPS methods 1 to 4 compared with pathologists' scoring. For all 584 samples of the tissue microarray, the OR for AI-assisted TPS methods 1 to 4 was 0.94 to 1.07 and not statistically significant. Of them, we found 332 discordant cases, on which the pathologists' judgments were inconsistent; the ORs for AI-assisted TPS methods 1, 2, 3, and 4 were 1.28 (1.06-1.54; P = .012), 1.29 (1.06-1.55; P = .010), 1.28 (1.06-1.54; P = .012), and 1.29 (1.06-1.55; P = .010), respectively, which were statistically significant. For discordant cases, the OR for each AI-assisted TPS method compared with the others was 0.99 to 1.01 and not statistically significant. This study emphasized the usefulness of the AI-assisted system for cases in which pathologists had difficulty determining the PD-L1 TPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
- Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan; Department of Diagnostic Pathology, Nara Medical University, Nara, Japan. Electronic address: akyoshi@kuhp.kyoto-u.ac.jp.
- Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Department of Advanced Information Technology, Kyushu University, Fukuoka, Japan.
- Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan; Department of Diagnostic Pathology, Toyooka Hospital, Hyogo, Japan.
- Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan; Department of Diagnostic Pathology, Tenri Hospital, Nara, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ito, H., Yoshizawa, A., Terada, K., Nakakura, A., Rokutan-Kurata, M., Sugimoto, T., Nishimura, K., Nakajima, N., Sumiyoshi, S., Hamaji, M., Menju, T., Date, H., Morita, S., Bise, R., & Haga, H. (2024). A Deep Learning–Based Assay for Programmed Death Ligand 1 Immunohistochemistry Scoring in Non–Small Cell Lung Carcinoma: Does it Help Pathologists Score?. Modern Pathology. https://doi.org/10.1016/j.modpat.2024.100485
Vancouver
Ito H, Yoshizawa A, Terada K, Nakakura A, Rokutan-Kurata M, Sugimoto T, et al. A Deep Learning–Based Assay for Programmed Death Ligand 1 Immunohistochemistry Scoring in Non–Small Cell Lung Carcinoma: Does it Help Pathologists Score?. Modern Pathology. 2024. doi:10.1016/j.modpat.2024.100485
BibTeX
@article{Ito2024,
author = {Ito, Hiroaki and Yoshizawa, Akihiko and Terada, Kazuhiro and Nakakura, Akiyoshi and Rokutan-Kurata, Mariyo and Sugimoto, Tatsuhiko and Nishimura, Kazuya and Nakajima, Naoki and Sumiyoshi, Shinji and Hamaji, Masatsugu and Menju, Toshi and Date, Hiroshi and Morita, Satoshi and Bise, Ryoma and Haga, Hironori},
title = {A Deep Learning–Based Assay for Programmed Death Ligand 1 Immunohistochemistry Scoring in Non–Small Cell Lung Carcinoma: Does it Help Pathologists Score?},
journal = {Modern Pathology},
year = {2024},
doi = {10.1016/j.modpat.2024.100485}
}
EUVIMED